Gold Down Over 1%; AC Immune Shares Spike Higher
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 50…
Why Is Health Care Company Fortrea Stock Diving Today?
Fortrea reported weak Q1 FY24 results and lowered its revenue outlook. Backlog at $7.4B, adjusted EBITDA declined, and EPS missed.
Auxly Cannabis Achieves Record Q1: Adjusted EBITDA Soars 1,523%, Revenue Grows 5%, Strong 2024 Ahead
Auxly Cannabis reports a record Q1 with 5% revenue growth and a 1,523% surge in adjusted EBITDA. Explore these impressive results.
Live Ventures Post 30% Hike In Q2 Sales As Acquisitions Boost
Despite operational challenges in Retail-Flooring segment, Live Ventures reporting $35.5 million gross profit and $4.5 million adjusted EBITDA in Q2 FY24.
HUYA Beats Revenue Estimates in Q1, Yet Faces Challenges in Game Streaming Sector
HUYA beats analyst estimates with $208.31M revenue in Q1 2024. Adjusted earnings per ADS was $0.05. Live streaming revenue declined, while game-related services and advertising revenue grew 137.6% Y/Y. Gross margin at 14.7%. Cash and equivalents at $1.30B.
US Stocks Higher; Tencent Music Shares Fall After Q1 Results
U.S. stocks traded higher this morning, with the Dow Jones gaining around 90 points on Monday. Following the…
StoneCo Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts
StoneCo Ltd. (NASDAQ:STNE) is set to release earnings results for its first quarter after the closing bell on…
Why Is Tencent Music Stock Trading Higher on Monday?
Tencent Music Group (NYSE: TME) exceeded analyst estimates with a Q1 revenue decline of 3.4%, driven by growth in online music services and higher gross margins.
How To Earn $500 A Month From Cisco Stock Ahead Of Q3 Earnings
Cisco has a dividend yield of 3.33%, which is a quarterly dividend amount of 40 cents a share ($1.60 a year).
Quince Therapeutics Updates Pipeline Progress, Eyes Enrollment for Pivotal Phase 3 Trial in Ataxia-Telangiectasia, Reported Q1 EPS Loss of $(0.26), Cash Balance of $67.8M
Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient's own biology to deliver rare disease therapeutics, today